← FDA DRUG APPROVALS

FDA ANDA · ANDA086107

THEOLAIR

Sponsor: 3M

APPLICATION
ANDA086107
TYPE
ANDA
ORIGINAL APPROVAL
1979-03-26
LATEST ACTION
1996-09-20
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

THEOLAIRDiscontinued
THEOPHYLLINE 80MG/15ML · SOLUTION · ORAL

Approval history

1996-09-20Labeling · Supplement 8AP
1991-06-12Labeling · Supplement 6AP
1985-06-18Manufacturing (CMC) · Supplement 4AP
1985-06-18Manufacturing (CMC) · Supplement 5AP
1983-02-18Manufacturing (CMC) · Supplement 1AP
1979-03-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →